Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Nu Holdings
NU
5
Liberty Latin America-A
LILA
US Stock MarketDetailed Quotes
BCLI Brainstorm Cell Therapeutics
- 0.8798
- +0.0098+1.13%
Trading Apr 24 11:54 ET
5.74MMarket Cap-0.38P/E (TTM)
0.8830High0.8607Low23.98KVolume0.8750Open0.8700Pre Close21.04KTurnover0.43%Turnover RatioLossP/E (Static)6.52MShares10.048552wk High-0.74P/B4.88MFloat Cap0.723352wk Low--Dividend TTM5.55MShs Float787.5000Historical High--Div YieldTTM2.56%Amplitude0.7233Historical Low0.8770Avg Price1Lot Size
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Brainstorm Cell Therapeutics Stock Forum
Major FDA Progress: New Phase 3b Trial Brings NurOwn ALS Treatment Closer to Approval
Major FDA Progress: New Phase 3b Trial Brings NurOwn ALS Treatment Closer to Approval
Just
Brainstorm Cell Therapeutics Submits Ind Amendment to FDA, Paving the Way for Phase 3B Trial of Nurown® in ALS
BrainStorm Cell Slashes Losses by 33%, Secures FDA Agreement for Major ALS Trial
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If...
Brainstorm Cell Therapeutics Granted Compliance Extension From Nasdaq
BrainStorm Cell Therapeutics Granted Compliance Extension from Nasdaq
Wednesday, 26th March at 8:15 am
NEW YORK, March 26, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading biotechnology company committed to the development and commercialization of best-in-class autologous cellular therapies for the treatment of neurodegenerative diseases, today announced that it has been granted the exact compliance extension it requeste...
No comment yet